ICU Medical Analyst Ratings
BenzingaFeb 28 05:03 ET
KeyBanc Reaffirms Their Buy Rating on ICU Medical (ICUI)
TipRanksFeb 28 02:45 ET
ICU Medical Analyst Ratings
BenzingaFeb 6 06:54 ET
ICU Medical Analyst Ratings
BenzingaDec 14, 2023 13:42 ET
Keybanc Adjusts Price Target on ICU Medical to $216 From $200, Keeps Overweight Rating
MT NewswiresMay 9, 2023 09:55 ET
Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $216
BenzingaMay 9, 2023 05:27 ET
ICU Medical Analyst Ratings
Benzinga Analyst RatingsNov 8, 2022 07:22 ET
KeyBanc Adjusts ICU Medical's Price Target to $225 from $230, Keeps Overweight Rating
MT NewswiresAug 9, 2022 08:50 ET
ICU Medical Price Target Cut to $190.00/Share From $208.00 by Raymond James
Dow JonesAug 9, 2022 08:21 ET
ICU Medical Is Maintained at Overweight by Keybanc
Dow JonesAug 9, 2022 04:43 ET
ICU Medical Price Target Cut to $225.00/Share From $230.00 by Keybanc
Dow JonesAug 9, 2022 04:43 ET
ICU Medical analyst ratings
Benzinga Analyst RatingsAug 9, 2022 04:34 ET
Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $225
Benzinga Real-time NewsAug 9, 2022 04:34 ET
Raymond James Adjusts Price Target on ICU Medical to $208 From $235, Keeps Outperform Rating
MT NewswiresAug 8, 2022 08:53 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: ICU Medical (ICUI), Twist Bioscience (TWST) and Alignment Healthcare (ALHC)
TipRanksAug 8, 2022 08:50 ET
ICU Medical Price Target Cut to $208.00/Share From $235.00 by Raymond James
Dow JonesAug 8, 2022 07:31 ET
ICU Medical analyst ratings
Benzinga Analyst RatingsAug 8, 2022 07:20 ET
Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $208
Benzinga Real-time NewsAug 8, 2022 07:20 ET
KeyBanc Adjusts Price Target on ICU Medical to $230 From $265, Reiterates Overweight Rating
MT NewswiresAug 3, 2022 04:56 ET
ICU Medical Price Target Cut to $230.00/Share From $265.00 by Keybanc
Dow JonesAug 3, 2022 04:44 ET
No Data
No Data